AI predicts swelling risk to guide breast cancer treatment choices

NCT ID NCT07187726

Recruiting now Knowledge-focused Sponsor: UNICANCER Source: ClinicalTrials.gov ↗

Summary

This study is testing whether an artificial intelligence (AI) tool can help patients and doctors make better decisions about breast cancer radiotherapy. The tool calculates a patient's personal risk of developing arm swelling (lymphedema) after treatment. Researchers will see if sharing this risk information changes treatment choices or helps patients manage their risk, like using a compression sleeve.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

CHI Créteil
RECRUITING

Créteil, France

Contact
Centre Antoine Lacassagne
RECRUITING

Nice, France
Centre Georges François Leclerc
RECRUITING

Dijon, France

Contact
Centre Guillaume Le Conquérant
RECRUITING

Le Havre, France

Contact
Centre Marie Curie
RECRUITING

Arras, France

Contact
Centre Pierre Curie
RECRUITING

Beuvry, France

Contact
Clinique Tivoli Ducos
RECRUITING

Bordeaux, France

Contact
Gustave Roussy
RECRUITING

Villejuif, France

Contact
ICO Nantes Saint Herblain
RECRUITING

Saint-Herblain, France

Contact
Institut Godinot
RECRUITING

Reims, France

Contact
Institut de Cancérologie Strasbourg Europe
RECRUITING

Strasbourg, France

Contact
ROC 37
RECRUITING

Chambray-lès-Tours, France

Contact

Conditions

Explore the condition pages connected to this study.

UNILATERAL BREAST NEOPLASMS